Bruker Corporation (BRKR)
Return on total capital
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 561,300 | 429,100 | 404,400 | 236,600 | 295,600 |
Long-term debt | US$ in thousands | 1,160,300 | 1,200,500 | 1,221,800 | 842,300 | 812,800 |
Total stockholders’ equity | US$ in thousands | 1,377,200 | 1,113,800 | 1,070,500 | 961,200 | 906,800 |
Return on total capital | 22.12% | 18.54% | 17.64% | 13.12% | 17.19% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $561,300K ÷ ($1,160,300K + $1,377,200K)
= 22.12%
Bruker Corp's return on total capital has fluctuated over the past five years. In 2023, the return on total capital was 18.27%, showing a slight decrease from 19.83% in 2022. Despite the decrease, the company's return on total capital remains relatively strong compared to previous years, where it ranged from 15.13% to 17.87%. This indicates that Bruker Corp has been efficient in generating profits from the total capital employed in its operations. Overall, the company has been maintaining a healthy return on investment, reflecting positively on its operational efficiency and capital utilization.
Peer comparison
Dec 31, 2023